Related Experiment Videos

Prevention of myocardial depression in experimental hemorrhagic shock by pretreatment with hydrocortisone

Insights

Hydrocortisone pretreatment effectively prevented myocardial depression in dogs experiencing hemorrhagic shock. This intervention maintained cardiac function, unlike in untreated control groups.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology
  • Shock Research

Background:

  • Hemorrhagic shock leads to myocardial depression, impairing cardiac contractility.
  • The protective effects of corticosteroids on the myocardium during shock are not fully understood.

Purpose of the Study:

  • To investigate the efficacy of hydrocortisone pretreatment in preventing myocardial depression induced by hemorrhagic shock.

Main Methods:

  • Ten dogs underwent cannulation of coronary arteries.
  • Hydrocortisone (4 mg/kg) was infused, followed by 90 minutes of hemorrhagic shock and retransfusion.
  • Cardiac contractile force (CF) and its first derivative (df/dt) were measured in pretreated and control myocardial regions.

Main Results:

  • The non-pretreated myocardial area showed a 50% reduction in CF and df/dt during shock.
  • The hydrocortisone-pretreated area maintained pre-shock levels of CF and df/dt.
  • Hydrocortisone prevented significant myocardial depression during hemorrhagic shock.

Conclusions:

  • Pretreatment with hydrocortisone effectively protects the myocardium against the depressive effects of hemorrhagic shock.
  • Hydrocortisone demonstrates a significant cardioprotective role in the context of shock-induced myocardial dysfunction.

Related Concept Videos